AmsG (encoded by the amsG gene) is a UDP-galactose-lipid carrier transferase that catalyzes the transfer of galactose from UDP-galactose to a lipid carrier during amylovoran biosynthesis . Amylovoran serves as a virulence factor, enabling bacterial colonization and obstruction of plant vascular systems . Recombinant AmsG refers to the enzyme produced via heterologous expression systems for functional and structural studies.
AmsG operates within the 12-gene ams cluster (amsA–amsL) . Key functions include:
Subunit Assembly: Anchors galactose to a lipid carrier, forming repeating oligosaccharide units of amylovoran .
Regulation: Expression is modulated by cyclic di-GMP (c-di-GMP) via CsrD, which stabilizes amsG mRNA .
Virulence Link: Mutants lacking amsG show reduced amylovoran production and impaired pathogenicity .
Recombinant AmsG is typically expressed in Escherichia coli for biochemical studies:
Cloning: The amsG gene is amplified from E. amylovora and ligated into expression vectors (e.g., pET series) .
Purification: Affinity chromatography tags (e.g., His-tag) enable high-yield isolation .
Activity Assays: Measured via UDP-galactose consumption or lipid-linked galactose detection .
| Condition | Effect on Amylovoran | Pathogenicity |
|---|---|---|
| amsG overexpression | Increased EPS production | Enhanced tissue necrosis . |
| amsG knockout | Reduced EPS synthesis | Attenuated disease progression . |
Biocontrol Strategies: Targeting AmsG could disrupt amylovoran synthesis, reducing bacterial virulence .
Agricultural Research: CRISPR-based genotyping of amsG aids in tracking E. amylovora outbreaks .
Enzyme Engineering: Recombinant AmsG serves as a model for studying glycosyltransferase mechanisms .